Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.
<h4>Background</h4>Prion-based diseases are incurable transmissible neurodegenerative disorders affecting animals and humans.<h4>Methodology/principal findings</h4>Here we report the discovery of the in vivo antiprion activity of Guanabenz (GA), an agonist of alpha2-adrenergi...
Guardado en:
Autores principales: | Déborah Tribouillard-Tanvier, Vincent Béringue, Nathalie Desban, Fabienne Gug, Stéphane Bach, Cécile Voisset, Hervé Galons, Hubert Laude, Didier Vilette, Marc Blondel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8eefe3241ca1455293c7d0b0209d1fe1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.
por: Florent Laferrière, et al.
Publicado: (2013) -
The physical relationship between infectivity and prion protein aggregates is strain-dependent.
por: Philippe Tixador, et al.
Publicado: (2010) -
Transcriptomic analysis brings new insight into the biological role of the prion protein during mouse embryogenesis.
por: Manal Khalifé, et al.
Publicado: (2011) -
Prion protein and Shadoo are involved in overlapping embryonic pathways and trophoblastic development.
por: Bruno Passet, et al.
Publicado: (2012) -
Highly Infectious Prions Generated by a Single Round of Microplate-Based Protein Misfolding Cyclic Amplification
por: Mohammed Moudjou, et al.
Publicado: (2014)